The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “An overview of current strategies and future prospects in drug repurposing in tuberculosis”.
No. |
Publication Date |
Citing Article |
1 |
2025 |
Geethu S. Kumar, Kuldeep Sharma, Richa Mishra, Esam Ibraheem Azhar, Vivek Dhar Dwivedi, Sharad Agrawal. Overcoming aminoglycoside antibiotic resistance in Mycobacterium tuberculosis by targeting Eis protein, In Silico Pharmacology. 2025; 13: 36. https://doi.org/10.1007/s40203-025-00325-5 |
2 |
2024 |
Anuradha Singh, Artificial intelligence for drug repurposing against infectious diseases, Artificial Intelligence Chemistry. 2024; 2: 100071100071. https://doi.org/10.1016/j.aichem.2024.100071 |
3 |
2025 |
Elham Amjad, Babak Sokouti. 2025; 305. https://doi.org/10.1016/B978-0-443-22326-6.00024-9 |
4 |
2024 |
Amey Deshpande, Rupali Likhar, Tabassum Khan, Abdelwahab Omri. Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges , Expert Review of Anti-infective Therapy. 2024; 22: 511. https://doi.org/10.1080/14787210.2024.2400536 |
5 |
2025 |
Sohal Satish, Nachiket Joshi, Rajasekhar Reddy Alavala, Afreen A. Khan. 2025; 965. https://doi.org/10.1007/978-981-96-4154-3_26 |
6 |
2025 |
Cemilenur Atas, Tuba Astarcioglu, Kubra Yildirim, Mehmet Akif Gun, Emel Kaynakci, Deniz Turgut Coban, Ahmet Yilmaz Coban. Evaluation of the Activity of Amoxicillin/Clavulanate, Ceftazidime/Avibactam and Colistin Against Drug-Resistant Mycobacterium tuberculosis Isolates by the E-test Method, Jundishapur Journal of Microbiology. 2025; 18: https://doi.org/10.5812/jjm-162034 |